Loading...
Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
Previous work has established the existence of dystrophin–nitric oxide (NO) signaling to histone deacetylases (HDACs) that is deregulated in dystrophic muscles. As such, pharmacological interventions that target HDACs (that is, HDAC inhibitors) are of potential therapeutic interest for the treatment...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
ScholarOne
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3667212/ https://ncbi.nlm.nih.gov/pubmed/23552722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2013.00011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|